Vésale

Health determinants and ethics

Social determinants, inequalities, consent and principles.

What determines health

The healthcare system explains only a minority of a population's health status. Social determinants — income, education, housing, work, environment — weigh more.

This is why health inequalities follow a continuous social gradient: they do not set the most deprived against everyone else, they are spread across every level of the social hierarchy.

The principles of medical ethics

Four principles frame the reasoning: patient autonomy, beneficence, non-maleficence and justice. They have no fixed order of priority, and it is precisely their conflict that defines an ethical problem.

Free and informed consent is the concrete expression of autonomy. It requires honest information, understanding of that information, and the absence of coercion — three conditions, not a signature.

Hippocrates, 17th-century engraving after an ancient bust.
Hippocrates, 17th-century engraving after an ancient bust. Image : Paulus Pontius / After Peter Paul Rubens, Public domain, Wikimedia Commons.

Four principles, and their tensions

Autonomy recognizes the patient's right to decide for themselves. Beneficence requires acting in their interest, non-maleficence not harming them. Justice demands a fair distribution of resources and care.

These principles regularly conflict, and ethics begins precisely there. Respecting the refusal of care by a patient whose life is at stake sets autonomy squarely against beneficence; neither principle automatically outweighs the other.

The law sets a framework without removing the difficulty. In France, the refusal of a conscious adult must be respected, but the law first requires repeating the information, allowing time for reflection and documenting the process. The designated trusted person conveys the patient's wishes without taking their place; advance directives, when they exist, take precedence over that testimony.

How the health system is organised

Health insurance, a branch of the social security system created in 1945, reimburses a large part of care; it is funded by contributions on earned income and by taxes, such as the general social contribution. Each year, Parliament votes a national health insurance spending target, which frames this spending. Complementary insurers cover part of what remains payable by patients.

Several agencies share the tasks. The French National Authority for Health assesses drugs and practices and publishes guidelines. The national medicines safety agency authorises clinical trials and monitors medicines and medical devices. Santé publique France monitors the population's health and carries out prevention. In each region, a regional health agency organises the provision of care.

Every patient over sixteen is asked to declare a referring doctor, who coordinates their care pathway; going directly to another specialist, apart from a few exceptions, is less well reimbursed.

Social inequalities in health

In France, life expectancy at birth for men among the wealthiest 5% exceeds that of men among the poorest 5% by about thirteen years; the gap is about eight years for women. These gaps do not only separate the poorest from everyone else: they follow a gradient, each social step having on average better health than the one below.

They are explained mainly by determinants lying outside the health care system: working and housing conditions, education, income, environment, and behaviours themselves shaped by living conditions. Access to care also contributes, through forgoing care for financial reasons or a shortage of doctors in some areas.

Schemes aim to reduce financial barriers: the solidarity complementary health cover, free or low-cost for people on low incomes, state medical aid for undocumented foreigners, and hospital access-to-care services. The principle of proportionate universalism proposes actions for everyone, but with an intensity that increases with the level of disadvantage.

End of life

Laws passed in 2005 and 2016 govern end-of-life care in France. They forbid unreasonable obstinacy: treatments that are useless, disproportionate or have no other effect than artificially maintaining life may be stopped or not started, including artificial nutrition and hydration, which are regarded as treatments. Palliative care, which relieves pain and supports the patient and their relatives, must then be provided.

When the patient can no longer express themselves, the decision to limit or stop treatment follows a collegial procedure: the doctor consults the team and at least one other doctor, looks for advance directives, then the opinion of the trusted person, failing that the family or relatives. Advance directives are binding on the doctor, except in an emergency while the situation is assessed, or if they appear clearly inappropriate.

At the patient's request, and in specific situations — serious and incurable illness, short-term life-threatening prognosis, refractory suffering — deep and continuous sedation maintained until death may be implemented. Its intention is to relieve suffering, not to cause death.

Research on human beings

Research ethics was born of crimes committed in the name of science. The Nuremberg Code, in 1947, after the trial of Nazi doctors, set voluntary consent as absolutely essential. The World Medical Association's Declaration of Helsinki, adopted in 1964 and revised since, spells out the rules: the interest of the person takes precedence over that of science and society, and risks must be proportionate to the expected benefit.

In France, any research involving the human person must receive a favourable opinion from a committee for the protection of persons, independent of the researchers, and, for the most interventional studies, authorisation from the medicines agency. The participant gives free and informed consent, which they can withdraw at any time without having to justify themselves. Vulnerable people — minors, adults under legal protection, people in emergency situations — enjoy reinforced protections. The data collected are protected by the European data protection regulation.

Organ donation and patients' rights

In France, organ donation after death is based on presumed consent: everyone is considered a donor unless they expressed refusal during their lifetime, mainly by registering on the national refusal register. Teams ask relatives whether the deceased had expressed any objection. Donation is free of charge, and anonymity between donor and recipient is preserved.

The law of 4 March 2002 enshrined patients' rights. The patient is entitled to clear information about their condition, the treatments proposed, their risks and the alternatives; in the event of a dispute, it is for the professional to prove the information was given. They have direct access to their medical record, without going through a doctor, within eight days, extended to two months for information more than five years old.

When harm occurs during care, the patient must be informed. Serious adverse events must be reported, not to find someone to blame, but to analyse their causes and prevent them from recurring.

58 answered questions go with this chapter in the practice section.

Sources and further reading

Reference textbooks

  • Tom L. Beauchamp, James F. Childress, Les principes de l'éthique biomédicale, Les Belles Lettres.

Open access

Last revised : . Text licensed under CC BY-SA 4.0.

The 3D atlas, the questions and progress tracking require JavaScript.